# Helicobacter Pylori Eradication Study

> **NCT03130452** · PHASE4 · COMPLETED · sponsor: **Inje University** · enrollment: 423 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Lansoprazole 30mg
- **DRUG:** Amoxicillin 1.0g Tab
- **DRUG:** Clarithromycin 500mg
- **DRUG:** Metronidazole 500 mg

## Key facts

- **NCT ID:** NCT03130452
- **Lead sponsor:** Inje University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-17
- **Primary completion:** 2019-01-28
- **Final completion:** 2019-05-31
- **Target enrollment:** 423 (ACTUAL)
- **Last updated:** 2025-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03130452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03130452, "Helicobacter Pylori Eradication Study". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03130452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*